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Impaired insulin secretion of aging: Role of renal failure and hyper-
parathyroidism. Available data indicate that insulin secretion is im-
paired with aging. Almost all the studies that examined insulin secretion
by old animals did not take into consideration the state of renal function
or the blood levels of parathyroid hormone (PTH). Old animals may
have chronic renal failure (CRF) and secondary hyperparathyroidism,
and both of these conditions impair insulin secretion. It is possible,
therefore, that the impaired insulin secretion of aging is not due to old
age per se, but rather to associated CRF and excess PTH. The present
study examined this issue in adult (6 month old) and senescent rats (2
years old) with and without CRF and excess PTH. Senescent rats
without CRF had normal renal function and normal blood levels of
PTH, and the values were not different from those observed in adult
rats. Creatinine clearance in senescent rats with CRF was significantly
(P <0.01) lower and serum levels of PTH were significantly (P <0.01)
higher than in senescent animals without CRF and than in the adult rats
as well. Only the senescent rats with CRF displayed glucose intolerance
during intravenous glucose tolerance test. For any given level of blood
glucose, plasma insulin levels were lower in senescent rats with CRF
than in the adult rat or senescent animals without CRF. Both initial
phase (139 45 pg/islet . 8 mm) and total (808 216 pg/islet . 33 mm)
insulin secretion from pancreatic islets of the senescent rats with CRF
and excess PTH were significantly lower than those in senescent rats
with normal renal function (658 117 pg/islet . 8 mm and 3294 290
pg/islet . 33 mm, respectively) or in adult rats (710 134 pg/islet . 8 mm
and 3183 366 pg/islet 33 mm, respectively). There were no signifi-
cant differences in insulin secretion between the adult rats and the
senescent ones with normal renal function. The data demonstrate that
the impaired insulin secretion by the pancreatic islets in old rats is not
necessarily related to the higher age per se, but is due to the associated
CRF and secondary hyperparathyroidism that develops in many, but
not all old animals. Our results indicate that studies examining the effect
of aging on body function should take into consideration the level of
renal function and of the serum PTH, since both CRF and excess PTH
adversely affect the functional integrity of many organs.
Abnormalities in glucose metabolism are commonly encoun-
tered in aged humans [1—3] and animals [4—6]. It is generally
accepted that aging is associated with impaired responsiveness
to the peripheral action of insulin [1—3], most likely due to a
postreceptor defect [7]. However, the data on the effects of
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aging on other aspects of glucose homeostasis are not uniform.
Indeed, normal [3, 7] or decreased [1—10] metabolic clearance
rate of insulin and impaired [4—6, 11—13] or normal [1, 14, 15]
insulin secretion were reported in old humans or animals. The
reasons for this variability are not evident.
The combination of peripheral resistance to the action of
insulin secondary to a postreceptor defect, decreased metabolic
clearance of insulin, and impaired insulin secretion are the
hallmarks of glucose intolerance of chronic renal failure (CRF)
[16]. CRF is associated with secondary hyperparathyroidism
and elevated blood levels of parathyroid hormone (PTH) [17],
and chronic exposure to excess PTH in the absence [18] or
presence of CRF impairs glucose-induced insulin secretion
[19—211. It is of interest that in the studies dealing with the effect
of aging on glucose homeostasis, the level of renal function and
the presence or absence of hyperparathyroidism have not been
evaluated nor considered in the interpretation of the results.
Both humans [221 and animals [23] may lose renal function to
a variable degree and may have secondary hyperparathyroidism
[24—27] with aging. Consequently, in an aged population of
humans or animals, one may find renal function to be normal,
moderately impaired, or even markedly reduced with or with-
out secondary hyperparathyroidism. Therefore, in order to
evaluate the effect of aging on glucose homeostasis, one must
study an aged population with normal renal function and
without elevated blood levels of PTH, and compare it with one
in which renal function is impaired and secondary hyperpara-
thyroidism is present.
This study examined glucose-induced insulin secretion by
pancreatic islets obtained from two groups of 24 month old rats
with and without CRF and secondary hyperparathyroidism. Six
month old rats with normal renal function and normal blood
levels of PTH served as controls.
Methods
Male Wistar rats weighing 430 to 600 g were obtained from
the aging colony of the Gerontology Research Center, National
Institute of Aging, Baltimore, Maryland, USA. Two groups of
rats were studied: a) six months old rats (adult rat) weighing 506
13 g and b) twenty-four month old rats (senescent rats) with
(weight 488 16 g) and without (weight 508 12 g) renal failure
and secondary hyperparathyroidism. It is noted that kidney
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disease (glomeruloscierosis and tubular atrophy) occurs in a
significant number of these rats belonging to this colony 128]. In
our studies, senescent rats were considered to have renal failure
if their serum creatinjne concentrations were twice and their
creatinine clearances were one half those of the six month old
animals, and to have secondary hyperparathyroidism when
their blood levels of PTH were more than twice those of the six
month old rats. Senescent rats which had values of serum
creatinine, PTH, and creatinine clearances not different from
those in the six month old animals were considered to have
normal renal function and no secondary hyperparathyroidism.
All rats were kept throughout their entire lives at room
temperature (22 to 24°C) with a photoperiods of 12 hours light
and 12 hours dark, and were maintained on standard National
Institutes of Health rat chow. This diet contains 25.3% protein,
1.2% calcium and 0.9% phosphorus. The rats were transferred
to our laboratory 7 to 10 days prior to the study and were
maintained at the same conditions. The animals were housed in
metabolic cages for collection of 24 hour urine samples.
One hour intravenous glucose tolerance test (IVGTT) was
done in the three groups of rats. The day before the study all
rats were weighed and anesthetized with intraperitoneal injec-
tion of 40 to 50 mg phenobarbitallkg body wt (Western Medical
Supply, Arcadia, California, USA). Through an incision of the
ventral surface of the neck, the jugular vein and carotid artery
were cannulated with PE-lO tubing filled with a solution of
sodium heparin (1000 lU/mI in 0.9% saline). The tubing was led
subcutaneously to emerge at the base of the neck. After
surgery, the animals were housed in individual cages and given
regular diet and water. IVGTT was performed the following day
after 12 hours of fasting and while the rats were awake. The
animals received 0.5 g of D-glucose/kg body wt as an intrave-
nous bolus injection. A total of six blood samples of 100 d each
were collected serially before and at 5, 15, 30, 45, and 60
minutes after the glucose injection from the arterial line for
measurement of glucose and insulin.
In another group of rats, insulin secretion from pancreatic
islets was examined. On the day of the experiments, the rats
were decapitated and the pancreata were removed, trimmed
free of adipose tissue and minced coarsely in ice-chilled Hank's
solution. The islets of Langerhans were isolated by the colla-
genase digestion method [29]. Their size was measured under
dissecting microscope. Glucose-induced insulin secretion was
evaluated by dynamic studies using a four channel perifusion
apparatus as described previously from our laboratory [201.
Twenty-five size-matched islets approximately 250 to 300 m in
diameter were placed in each of the four conical chambers of
0.07 ml capacity, and were perifused at a rate of 0.8 mI/mm with
the incubation media containing 2.8 msi D-glucose at a temper-
ature of 37°C and a gas mixture of 95% 02 and 5% CO2. The
incubation media was a modified Krebs-Ringer bicarbonate
buffer (pH 7.4) containing 10 mri HEPES and 0.5 g/dl bovine
serum albumin. After leaving the chambers, the perifusate was
filtered through 8.0 pm pore size filter (Sartorius, Burlingam,
California, USA) and was collected. Each study was performed
in duplicates. After 39 minutes of pre-incubation, the collection
of the effluent was started and continued at a one minute
interval for 41 minutes. The first six collections (6 mm) repre-
sented the basal level of insulin during perifusion with 2.8 mt
D-glucose. Thereafter, the D-glucose concentration in the pen-
fusate was increased to 16.7 m and an additional 35 samples
were collected. Insulin concentration was then determined in
the various samples of the effluent by the charcoal coated
immunoassay using rat insulin as standard [30].
The changes in insulin secretion from baseline over time were
evaluated by calculating the area under the curve for each study
utilizing the trapezoidal rule. Insulin release from the islets
started to increase two minutes after the change in the concen-
tration of D-glucose in the perifusate to 16.7 m. The average
value of the insulin release prior to that (8 mm) was used as the
basal insulin release in response to 2.8 msi D-glucose. Area
under the curve in the first eight minutes (minute 2 to 10) after
the exposure of the islets to 16.7 mrvi D-glucose was calculated
and considered to be the initial phase of insulin secretion. The
total insulin release was calculated for 33 minutes (minute 2 to
35). The area under the curve of insulin release and the area
under the curve for plasma glucose during IVGTF in each of the
various groups of rats as well as the different biochemical data
were compared with each other by one way analysis of variance
using the Duncan multiple range test.
In another set of rats (3 in each groups) the pancreata were
fixed in 10% (buffered) formaldehyde and embedded in paraffin
after routine processing in a tissue processor. Sections were cut
at a 5 micrometer. One section from each rat was stained with
hematoxylin and eosin. A parallel section was stained by
immunoperoxidase technique using an antibody against insulin.
Urine creatinine was measured with a creatinine kit from
Stanbio Laboratory, San Antonio, Texas, USA; serum levels of
creatinine and phosphorus were determined with a Technicon
autoanalyzer (Technicon Instruments Inc., Tarrytown, New
York, USA) and serum concentrations of calcium and magne-
sium were estimated with a Perkin Elmer atomic absorption
spectophotometer model 503 (Perkin Elmer Corp., Norwalk,
Connecticut, USA). PTH levels in serum were determined by a
INS-PTH immunoassay kit (Nichols Institute Diagnostics, San
Juan Capistrano, California, USA). This assay recognizes the
aminoterminal fragment of PTH. The assay showed highly
reproducible 1C50 for inhibition of '251-PTH binding of 21.4
0.8 pg and less than 10% differences within an assay. A sample
volume of 120 l was used for most of the assays. Dilutions
were made when necessary and the final result was based on the
lowest dilutions.
Results
Table 1 presents the weight and the biochemical data in the
three groups of animals. The weight of the senescent rats with
or without CRF or secondary hyperparathyroidism was not
different from that of the adult rats. The concentrations of
BUN, plasma levels of creatinine, calcium, and magnesium and
serum PTH and the value of creatinine clearance in the 24
month old rats without CRF were not different from those in the
6 month old rats. In contrast, the 24 month old rats with CRF
had significantly (P < 0.01) higher levels of BUN, plasma
creatinine and serum PTH, and lower values of creatinine
clearance than the 24 month old rats without CRF and the 6
month old rats as well; the concentrations of plasma calcium
and magnesium in these two groups of senescent rats were not
different. The concentrations of plasma phosphorus in the 24
month old rats with or without CRF were significantly (P <
0.01) lower than the values in the 6 month old rats. This
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Table 1. Biochemical data and insulin secretion from pancreatic islets in adult (6 months old) and in senescent (24 month old) rats with and
without chronic renal failure and secondary hyperparathyroidism
Insuun secretion
Body
weight
g BUN
Plasma levels mg/dl Serum1-34 P1'H
Mg pg/ml
Creatinine
clearance
pJ/min/
100 g
pg/islet
Early Total
8 mm 33 mmCr Ca P
I. Six month old 506 13 29 1.7 0.39 0.02 10.4 0.23 7.1 0.25 2.4 0.07 39 2.9 554 54 710 134 3813 366(N=ll) (N=6)
2. Twenty-four
months old
a. Without CRF 508 12 36 4.8 0.49 0.02 10.1 0.07 5.3 0.18° 2.5 0.12 41 5.9 432 62 658 117 3294 290
(N= 13) (N=6)
b. With CRF and 488 16 80 8.2a 1.18 0.09a 10.4 0.21 5.2 0.2la 2.8 0.14 112 17.9a 204 23° 139 45° 808 216°
2° HPTISM (N = 7)(N = 12)
Data are presented as mean SE. Abbreviations are: BUN, Blood urea nitrogen; Cr, creatinine; Ca, calcium; P, phosphorus; Mg, Magnesium;
CRF, chronic renal failure; 2° HPTISM, secondary hyperparathyroidism.
P < 0.01 from other groups
observation is similar to previously reported data on the con-
centration of serum phosphorus in old Wistar rats [281.
Figure 1 shows the changes in the plasma levels of glucose
during IVGTT in the three groups of animals. The plasma levels
of glucose reached their peak within five minutes after the
injection of glucose load and decreased thereafter. The senes-
cent rats with CRF and secondary hyperparathyroidism dis-
played glucose intolerance with the area under the curve for
their plasma glucose (13157 1103 mgldl . 60 mm) being
significantly (P < 0.05) higher than that in the senescent rats
without CRF (9530 530 mgldl 60 mm) or the adult rats
(10178 180 mgldl• 60 mm). The values in the latter two
groups were not different. There were significant increments in
plasma insulin levels in adult and senescent rats without CRF
but only small changes in senescent rats with CRF and second-
ary hyperparathyroidism (Fig. 2). Indeed for any given plasma
glucose levels, the plasma insulin levels were higher in the adult
and senescent rats without CRF than in the senescent rats with
CRF and secondary hyperparathyroidism (Fig. 3).
Both the initial phase and the total amount of glucose-induced
insulin secretion by pancreatic islets from 24 month old rats
without CRF or secondary hyperparathyroidism were not dif-
ferent from the corresponding values observed in the 6 month
old rats (Table 1, Fig. 4). In contrast, the senescent rats with
CRF and elevated serum levels of PTH displayed marked and
significant (P < 0.01) reductions in the amount of insulin
secreted in the initial phase of the glucose-induced insulin
release as well as in the total amount of insulin secreted during
the 33 minutes of perifusion studies (Table 1, Fig. 4).
Figure 5 shows the histology of the pancreatic islets from
adult and senescent rats with and without CRF. In all three
groups of animals, the islets were normal in size, distribution,
cellularity and structure, and there were no evidence of fibrosis
or lymphocytic infiltration. Immunoperoxidase stain for insutin
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Fig. 1. The changes in the plasma levels of glucose during intravenous
glucose tolerance test performed in the three groups of animals: (0) six
months; (0) 24 months — CRF; (U) 24 months + CRF. Each datum
point represents mean value of 5 to 7 experiments and brackets denote
1 SE.
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Fig. 2. The changes in plasma insulin levels during intravenous glu-
cose tolerance test performed in the three groups of animals. Symbols
are: (0) 6 months; (El) 24 months — CRF; (•) 24 months ÷ CRF. Each
datum point represents mean value of 5—7 experiments and brackets
denote I SE.
0 15 30 45 60
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Plasma glucose, mgldl
Fig. 3. The relationship between plasma levels of insulin and glucose
observed during the intravenous glucose tolerance test performed in the
three groups of animals. Symbols are: (0) six months, (LII) 24 months
without CRF, (U) 24 months with CRF. One animal of senescent rats
with CRF had insulin levels of 1 or more ng/ml. It is this animal which
makes the data of CRF rats appear to overlap with the data of the other
two groups of rats. Without this one animal, the separation between
insulin levels of old rats with CRF and the two groups of rats is more
clear.
showed that 70 to 80% of the cells in the islets from the three
groups of animals were beta cells that stained positively for
cytoplasmic insulin.
Discussion
The results of the present study demonstrate that glucose
intolerance is present in senescent rats with CRF and secondary
hyperparathyroidism, but not in senescent rats without CRF
and with normal levels of plasma PTH. Also, the plasma levels
of insulin during the IVGTT in the senescent rats with CRF and
excess PTH did not increase as much as in the other two groups
of rats. Indeed, for any given plasma levels of glucose, the
plasma insulin levels were lower in the senescent rats with CRF
than in the senescent rats without CRF or in adult rats. These
observations are consistent with reduced glucose-induced insu-
lin secretion in senescent rats with CRF. The results of the
perifusion studies of the pancreatic islets provide definite sup-
port for this notion in that islets from senescent rats with CRF
and elevated blood levels of PTH displayed a marked and
significant reduction in the initial phase as well as in the total
amount of glucose-induced insulin secretion. This is in contrast
to the normal glucose-induced insulin secretion by pancreatic
islets of senescent rats without CRF and normal plasma levels
of PTH.
Although the area under the curve for insulin during the
IVGTT in old rats with CRF is significantly lower than in adult
and old rats without CRF, the plasma insulin levels at 15, 30, 45
and 60 minutes were not significantly different. The reason for
this latter finding is, most likely, due to different rates of insulin
clearance. In the adult and old rats without renal failure, insulin
levels declined faster than in old rats with CRF since the latter
impairs insulin degradation [311. Despite the small differences in
plasma insulin levels at 15, 30, 45 and 60 minutes among the
three groups of animals, the old rats with CRF had hypergly-
Time, minutes
Fig. 4. Dynamic glucose-induced insulin secretion by perfused pan-
creatic islets isolated from six adult (6 months old) rats (shaded area),
six senescent (24 months old) rats with CRF and secondary hyperpara-
thyroidism (U) and seven senescent (24 months old) rats without CRF
or secondary hyperparathyroidism (0). The shaded area encompasses
the mean value 1 SE. Each datum point represents mean value and
brackets denote I SE.
cemia. Further, hyperglycemia was also present at baseline in
these animals despite plasma insulin levels similar to those in
adult rats and old rats without CRF. These observations
strongly suggest that old rats with CRF and excess PTH have
peripheral resistance to the action of insulin.
The differences in glucose-induced insulin secretion between
the islets of the two groups of senescent rats could not be
attributed to variations in their weight, differences in protein
intake, the concentration of serum calcium, phosphorus and
magnesium, or the histology of the pancreatic islets since there
were no significant differences between these parameters.
It has been shown that the pancreas of old rats contains
greater number of large islets [32—35]. Kitahara and Adelman
[36] have demonstrated that large islets secrete more insulin
than smaller islets irrespective of age of the rat. In order to
avoid the effect of islet size on insulin secretion by different
groups of rats, one must exercise great caution in matching the
size of the islets used for the study. We indeed matched the size
of the islets obtained from our adult rats and the two groups of
senescent rats. Therefore, the differences in insulin secretion
observed in the rats of our study could not be accounted for by
differences in islet size.
Our observations indicate that an impairment in insulin
secretion that may occur with aging [4—6, 11—13] is not neces-
sarily related to the higher age, but is most likely secondary to
the effect of associated disease processes, such as CRF and
secondary hyperparathyroidism, that may develop with aging
[22—27]. Indeed, several lines of evidence indicate that even in
adult or young animals, CRF impairs glucose-induced insulin
secretion, and this effect is due to the secondary hyperparathy-
roidism of CRF [18—21]. Akmal et al, utilizing hyperglycemic
clamp studies, showed that insulin secretion in adult dogs with
CRF is impaired [19], and Fadda et al [20, 21] demonstrated that
glucose-induced insulin secretion by pancreatic islets isolated
from young rats with CRF displayed marked reduction in both
the initial phase and the total amount of insulin secretion. This
defect in insulin secretion was corrected by prior parathyroid-
ectomy [19—2 1]. Mak et al [37] confirmed these observations in
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Fig. 5. Light microscopy of histological sections of islets from adult rats (A), senescent rats without CRF (B) and senescent rats with CRF and
secondary hyperparathyroidism (C), (H & E X 100).
children with CRF. In addition, Perna et a! [18] reported that
insulin secretion by pancreatic islets isolated from young rats
with normal renal function but treated with PTH for six weeks
is impaired. Thus, it is apparent that chronic excess of PTH in
the presence or absence of CRF impairs glucose-induced insulin
secretion.
It is of interest that Molina, Premdas, and Lipson [13] found
that while glucose-induced insulin release by islets from old rats
is impaired, glyceraldehyde-induced insulin secretion is normal.
These observations are consistent with the notion that an
abnormality in glucose metabolism at or after the level of
glucokinase and before the level of triose phosphate is present
in the islets of old rats. Similar observations were found in
young rats with CRF [21] and in young normal rats treated with
PTH [18]. In these animals glucose-induced insulin release was
impaired but glyceraldehyde-induced release was normal.
All these observations taken together and the results of the
present study strongly support the proposition that the impair-
ment in insulin secretion of aging is, at least, partly due to the
state of renal failure and the associated secondary hyperpara-
thyroidism that is frequently present in aged humans and
animals [22—27].
The mechanisms responsible for the impaired insulin secre-
tion by islets from young rats with excess PTH in the presence
or absence of CRF have already been studied in detail [18, 21].
These include a significant rise in resting levels of cytosolic
calcium, a decrease in basal levels of ATP, a small increment in
islet ATP in response to glucose, and a defect in glucose
metabolism of the islet. Although these parameters were not
examined in the present study, it is reasonable to suggest that
islets from old rats with CRF and secondary hyperparathyroid-
ism display similar cellular derangements as islets from young
rats with CRF and elevated blood levels of PTH.
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